Triangle Laboratory adds the Cut Point Statistical Service to Immunogenicity Studies

Apr 8, 2022 | News

Triangle Laboratory, a leading bioanalytical testing laboratory specializing in ligand binding and cell-based assays, announced today the introduction of statistical service to immunogenicity studies. Dr. Liu, Head of Bioanalysis at Triangle Laboratory said: “unlike...

Dramatically Enhanced Drug Tolerance with Maintained Sensitivity of Peptide Products for ADA Study Using a Novel Method

Nov 4, 2021 | Case Studies

Background Due to their distinct biochemical and therapeutic characteristics, peptides have been developed as drug candidates to disrupt protein–protein interactions and target intracellular molecules such as receptor tyrosine kinases. These have turned peptide...

Triangle Laboratory Validated Study for SARS-CoV-2 Positive Samples by Heat Inactivation

Oct 5, 2021 | News

Triangle Laboratory Inc., a contract research organization (CRO), is the drug development company supporting comprehensive large molecule bioanalysis services. We recently developed and validated a pharmacokinetics study which requires to analyze samples with...

Triangle Laboratory Launches Bioanalytical Services to COVID-19 Projects

Jun 24, 2020 | News

Triangle Laboratory, a leading bioanalytical testing laboratory specializing in ligand binding and cell-based assays, announced today the bioanalytical service to COVID-19 related studies. Dr. Liu, Head of Bioanalysis at Triangle Laboratory said: “To support the...

Development of Electrochemiluminescence Immunoassay for the Quantitation of RF001 in Human Serum

Apr 3, 2020 | Case Studies

Principle A sandwich based ligand binding assay was developed by Triangle Laboratory for the quantitation of RF001 in human serum (Figure1). In brief, validation samples are diluted and transferred into MSD plate, which pre-adsorbs Capture antibody (Clone#D5B). After...